96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
Conjugated hepcidin mimetics
#1202Compounds for selective disruption of protein-protein interactions
#1203Polypeptide having analgesic activity and use thereof
#1204Marker for predicting the sensitivity to PI3K inhibitors
#1205ANTI-FOULING PAINTS AND COATINGS
#1206Peptide inhibitors of insulin-degrading enzyme
#1207METHOD FOR ACTIVATING HELPER T CELL
#1208LYTIC-PEPTIDE-HER2/NEU (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) LIGAND CONJUGATES AND METHODS OF USE
#1209Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
#1210Composition for prevention or treatment of hair loss
#1211N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same
#1212COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#1213Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide
#1214Methods for treating cancer
#1215Immunotherapy against neuronal and brain tumors
#1216METHODS OF QUANTIFYING CFTR PROTEIN EXPRESSION
#1217Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#1218THERAPEUTIC CONSTRUCTS COMPRISING CMET BINDING PEPTIDES
#1219Short TAT oligomers for drug delivery
#1220Peptide for suppressing osteoclast differentiation and use thereof
#1221Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
#1222Anti-tumour immune responses to modified self-epitopes
#1223Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1224Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1225Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
#1226CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
#1227Drug Delivery Enhancement Agents
#1228Method of treating with a peptide
#1229Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1230Stabilized polypeptides and uses thereof
#1231Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of Alzheimer's disease
#1232FOXP3-binding peptides and uses thereof
#1233Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1234Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1235Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1236Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1237Method of facilitating the bindings between keratinocytes
#1238Thioredoxin 1 epitope, encoding nucleic acid and methods of binding a monoclonal antibody
#1239Stapled intracellular-targeting antimicrobial peptides to treat infection
#1240Solution-phase affinity selection of inhibitors from combinatorial peptide libraries
#1241α4α7 peptide monomer and dimer antagonists
#1242PEPTIDE INHIBITORS OF HCV NS3/4A PROTEASE COMPRISING NON-PROTEINOGENIC AMINO RESIDUES
#1243Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1244Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1245Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1246DEPDC1-derived peptide and vaccine containing same
#1247Crosslinked hydrogel compositions for regulating states of encapsulated cancer cells
#1248Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof
#1249COMPOSITIONS AND METHODS FOR REDUCING IMMUNE RESPONSES AGAINST CHIMERIC ANTIGEN RECEPTORS
#1250Activation of bioluminescene by structural complementation
#1251Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1252Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
#1253IL-2Rgamma binding compounds
#1254IL-2RBETA binding compounds
#1255Activatable membrane-interacting peptides and methods of use
#1256Bicyclic peptide ligands specific for MT1-MMP
#1257Method of treating with a peptide
#1258RAPID TEST FOR CELLULAR FIBRONECTIN
#1259Bifunctional peptide having capability to reduce inflammation and capability to facilitate differentiation of stem cells into chondrocytes and use thereof
#1260AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
#1261Treatments for Gastrointestinal Disorders
#1262Engineered cascade components and cascade complexes
#1263Peptide compositions and methods of use thereof
#1264Therapeutic cationic peptides and unimolecular nanoparticles for efficient delivery thereof
#1265MAFG AS A POTENTIAL THERAPEUTIC TARGET TO RESTORE CHEMOSENSITIVITY IN PLATINUM-RESISTANT CANCER CELLS
#1266MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF
#1267Cancer treatment drug
#1268Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
#1269Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)
#1270SEROLOGICAL ASSAY FOR DETECTION OF EXPOSURE TO AND INFECTION BY TICK-BORNE PATHOGENS
#1271Therapeutic DLL4 Binding Proteins
#1272Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#1273Peptide derivative and pharmaceutical composition containing same
#1274Peptide oligonucleotide conjugates
#1275Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1276Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#1277Agents modulating beta-catenin functions and methods thereof
#1278Polypeptides for the treatment of diseases
#1279Peptide agonists and antagonists of TLR4 activation
#1280Alpha conotoxin peptides
#1281CHLAMYDIA SUIS DIAGNOSIS
#1282Use of Specific Covalent Bonding for Oriented Immobilization of Recombinant Antibody Fragments
#1283Peptoid polymers and methods of use
#1284Ras inhibitory peptides and uses thereof
#1285NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
#1286Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery
#1287Noxa-derived, cell death-inducing peptide eMTD
#1288Polypeptide eye absorption enhancer and use thereof
#1289Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions
#1290Antimicrobial adhesive protein, antimicrobial nanoparticle, antimicrobial composition comprising same nanoparticle, and preparation method for same composition
#1291Antimicrobial peptide derived from myxinidin peptide and uses thereof
#1292Peptide inhibitors of twist
#1293Antimicrobial peptides and methods of using the same
#1294DPEP-1 binding agents and methods of use
#1295Synthetic bioconjugates
#1296LINACLOTIDE COMPOSITIONS
#1297TISSUE OCCLUDING AGENT
#1298Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof
#1299Integrin Antagonists
#1300Peptides for treatment and prevention of hyperglycaemia
#1301Immunomodulators
#1302Antimicrobial peptide derived from Hp1404 peptide and uses thereof
#1303Methods and compositions related to inhibition of viral entry
#1304Antibodies and peptides to treat HCMV related diseases
#1305PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES
#1306PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE
#1307Suppression of allergic lung inflammation and hyperreactivity
#1308JNK Inhibitor Molecules For Treatment Of Various Diseases
#1309Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1310Peptide library and use thereof
#1311Supramolecular filamentous assemblies for protein purification
#1312EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY
#1313Circular tandem repeat proteins
#1314Use of tetranectin and peptide agonists to treat inflammatory diseases
#1315NEMO coiled coil mimics and methods of using same
#1316Antimicrobial peptides and their use
#1317Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion
#1318Targeting α2δ-1-bound glutamate receptors for treating diseases and disorders
#1319Compstatin analogs with increased solubility and improved pharmacokinetic properties
#1320Peptides for binding epidermal growth factor
#1321Therapeutic peptides
#1322Site-specific radioisotope-labeled antibody using IgG-binding peptide
#1323Recrystallization inhibitor
#1324PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF VIRUS
#1325USP30 INHIBITORS AND METHODS OF USE
#1326INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION
#1327Bicyclic peptide ligands specific for MT1-MMP
#1328Reactive peptide labeling
#1329Compositions and methods for treating pulmonary hypertension
#1330Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#1331Molecular imaging of cancer cells in vivo
#1332MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#1333PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF
#1334Polypeptide derived from CAP1 and pharmaceutical composition comprising same as effective ingredient
#1335Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1336KOC1-derived peptide and vaccine including same
#1337Lysine monomethylated derivative and corresponding antibody and use thereof
#1338Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same
#1339Fibroblast growth factor receptor 2-specific peptide reagents and methods
#1340Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1341Micropeptides and use of same for modulating gene expression
#1342Bicyclic peptide ligands and uses thereof
#1343POLYPEPTIDE WITH TUMOUR BINDING ACTIVITY
#1344Peptides and methods and uses thereof for modulating anaphase promoting complex (APC) activity
#1345MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#1346PEPTIDES AND NEMATICIDAL COMPOSITIONS
#1347Modulation of complement activity
#1348Peptide compositions and methods of use
#1349Telomerase polypeptide vaccine for treating cancer
#1350Anti-HIV peptides
#1351Antiplasmodial compounds
#1352Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods
#1353Method of sensitizing cancer cells to anti-cancer treatment
#1354AGONISTS OF GUANYLATE CYCLASE USEFUL FOR DOWNREGULATION OF PRO-INFLAMMATORY CYTOKINES
#1355Compositions for expanding regulatory T cells (Treg) populations, and treating and ameliorating autoimmune diseases and conditions
#1356Anti-microbial peptides
#1357Short synthetic peptide and uses thereof
#1358INHIBITORS OF PROTEINS SPECIFIC FOR THE SECRETOME OF A CHONDROCYTE FOR USE IN THE TREATMENT OF BREAST CANCER METASTASIS
#1359Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1360Peptide that regulates fat metabolism and method for regulating fat metabolism
#1361PEPTIDE REAGENTS AND METHODS FOR DETECTION AND TARGETING OF DYSPLASIA, EARLY CANCER AND CANCER
#1362Antigen-specific tolerance and compositions for induction of same
#1363Peptides and compositions for prevention of cell adhesion and methods of using same
#1364MODULATION OF THE IMMUNE RESPONSE
#1365Agrobacterium derived cell penetrating peptides as nanocarriers
#1366Peptides capable of reactivating p53 mutants
#1367Melanocortin Receptor Ligands
#1368Peptides and combination of peptides for use in immunotherapy against various cancers
#1369Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1370Vista antagonist and methods of use
#1371Labyrinthopeptins as anti-viral agents
#1372URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME
#1373BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES
#1374Prostate-specific membrane antigen (PSMA) targeting peptides
#1375PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#1376Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif
#1377Antibodies binding to TLR2/TLR4-interacting immunologically active polypeptide
#1378Powerful MHC-class II peptides derived from survivin
#1379Conotoxin peptides for use in biofouling deterrence
#1380Inhibitors of prototypic galectin dimerization and uses thereof
#1381Mycobacteria tuberculosis chaperonin 60.1 peptides and uses thereof
#1382Biocidal peptide and preparation based thereon
#1383ANTIMICROBIAL PEPTIDES
#1384THERAPEUTIC PEPTIDES
#1385Composition for improving hair health
#1386Specific GNAI:GIV interaction screening assays, methods and compositions
#1387METHOD FOR SEPARATING AND PURIFYING MUSSEL ADHESIVE PROTEIN
#1388Peptides and compositions for prevention of cell adhesion and methods of using same
#1389Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
#1390Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
#1391NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF
#1392PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#1393Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#1394Method of treating with a peptide
#1395Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1396Engineered cascade components and cascade complexes
#1397Multivalent ligand-lipid constructs
#1398INFLUENZA VIRUS NEUTRALIZING COMPOUNDS
#1399Antimicrobial peptides and methods of making and using same
#1400Peptide-polynucleotide complex for polynucleotide transfection
#1401Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1402POLYPEPTIDE SPERM STABILISER FOR SEMEN USED IN ARTIFICIAL INSEMINATION
#1403Process of Preparing Guanylate Cyclase C Agonists
#1404IL-2Rγ binding compounds
#1405Antimicrobial peptide having synergistic antibacterial effect with antibiotics on multidrug resistant bacteria, and use thereof
#1406IL-2RBeta binding compounds
#1407Epitope tag and method for detection and/or purification of tagged polypeptides
#1408PSMA-specific binding proteins
#1409Dosing regimens and related compositions and methods
#1410Peptides that block leukocyte recruitment and methods of use
#1411Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis
#1412MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#1413Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1414Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1415Immunotherapy against several tumors including lung cancer
#1416Immunotherapy against several tumors including lung cancer
#1417PEPTIDE INHIBITORS OF SODIUM CHANNELS
#1418FC receptor (FcRn) binding peptides and uses thereof
#1419PHOSPHORYLATION OF HISTONES AND USES THEREOF
#1420Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment
#1421Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory
#1422Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1423Peptides and methods of using same
#1424NOVEL a4B7 PEPTIDE ANTAGONISTS
#1425Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1426Agonist of spexin-based galanin type 2 receptor and use thereof
#1427Glypican-3 peptide reagents and methods
#1428Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments
#1429Antibacterial cyclic lipopeptides
#1430SYNTHESIS OF MULTIPHOSPHORYLATED PEPTIDES
#1431FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#1432Methods of reducing neuronal injury or toxicity in epilepsy, Alzheimer's disease or Parkinson's disease using a scorpion venom heat-resistant synthetic peptide (SVHRSP)
#1433Modulation of complement activity
#1434AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE
#1435Melanocortin 1 receptor ligands and methods of use
#1436Process for the preparation of a dodecapeptide
#1437Peptides and combination of peptides for use in immunotherapy against various cancers
#1438Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1439Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1440Synthetic polypeptides and uses thereof
#1441Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1442PEPTIDE LIGANDS FOR BINDING TO MT1-MMP
#1443Bicyclic peptide ligands specific for Nectin-4
#1444COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE
#1445Conformational mimotopes for detecting specific antibodies
#1446Methods for detecting peptide/MHC/TCR binding
#1447Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#1448Peptide based inhibitors of Raf kinase protein dimerization and kinase activity
#1449Erythrocyte-binding therapeutics
#1450Methods and compositions for the treatment of cancer
#1451pH-sensitive cyclic peptides
#1452Zinc-binder based EBNA1-specific compounds
#1453Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1454Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#1455NEW D-CONFIGURED CATESLYTIN PEPTIDE
#1456Multi-target peptide molecules of opioid and neuropeptide FF receptor, preparation for molecules, and applications thereof
#1457IMMUNE SYSTEM MODULATORS
#1458METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES
#1459CTLA4/PD1 targeted/immunomodulatory fusion proteins
#1460Solid-phase support comprising IgG-binding peptide, and method for separating IgG
#1461Vasoactive polypeptides for smooth muscle relaxation
#1462ANTIBODY/DRUG CONJUGATES AND METHODS OF USE
#1463Influenza Peptides and Compositions
#1464NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF
#1465Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1466SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED
#1467Compositions comprising peptide WKDEAGKPLVK
#1468Peptides and methods for the treatment of diabetes
#1469Peptide compounds to regulate the complement system
#1470PEPTIDE INHIBITOR OF TRANSMEMBRANE PORE FORMATION AND EFFLUXPUMP FUNCTION IN A SMALL MULTIDRUG RESISTANCE PROTEIN FROM PSEUDOMONAS AERUGINOSA
#1471INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#1472Antimicrobial peptides with wound healing activity
#1473BRAIN TARGETING LONG-ACTING PROTEIN CONJUGATE
#1474Peptide binding to arsenic-containing mineral and use thereof
#1475Peptide and use thereof
#1476Laminin receptor peptides for therapy
#1477Peptidomimetic macrocycles
#1478PRODUCTION METHOD FOR NONCYCLIC PEPTIDE-NUCLEIC ACID COMPLEX HAVING, AT N-TERMINAL, AMINO ACID WITH THIOL GROUP NEAR AMINO GROUP, LIBRARY THEREOF, AND CYCLIC PEPTIDE-NUCLEIC ACID COMPLEX LIBRARY DERIVED FROM SAME
#1479Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1480Modified peptides
#1481Cell penetrating peptides with improved internalization properties
#1482Anti-microbial peptides and method for designing novel anti-microbial peptides
#1483Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#1484Immunomodulatory peptide
#1485NOVEL MUTANT OF a-CONOTOXIN PEPTIDE TxID, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#1486PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#1487Methods for treating cancer
#1488Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
#1489Peptide having skin-whitening activity and use thereof
#1490Colon and pancreas cancer specific antigens and antibodies
#1491Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1492Tricalcium Phosphate Binding Peptides And Uses Thereof
#1493Compositions and methods for transport across the blood brain barrier
#1494FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#1495Immunotherapy against neuronal and brain tumors
#1496METHOD FOR ENHANCING EXTRACELLULAR VESICLE PRODUCTION
#1497Complexes for gene deletion and editing
#1498SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES
#1499TARGETED NONINVASIVE IMAGING PROBES OF EGFR EXPRESSING CELLS
#1500Peptides capable of reactivating p53 mutants